Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator Publication Simcyp 群体模拟器中 PBPK 建模复合文件开发指南 The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…Certara2024 年 2 月 23 日
Off-Target Drug Safety: Replacing Educated Guesswork with Evidence-Based Risk Assessment On-Demand Webinar 药物脱靶安全性:Replacing Educated Guesswork with Evidence-Based Risk Assessment ToxStudio integrates safety and toxicology software to address three critical areas in preclinical safety: Cardiac…Certara2023 年 12 月 19 日
Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Publication Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…Certara2023 年 6 月 28 日
Model-Informed Approaches and Innovative Clinical Trial Design for Adeno-Associated Viral Vector-Based Gene Therapy Product Development: A White Paper Publication Model-Informed Approaches and Innovative Clinical Trial Design for Adeno-Associated Viral Vector-Based Gene Therapy Product Development: A White Paper The promise of viral vector-based gene therapy (GT) as a transformative paradigm for treating severely…Certara2023 年 6 月 14 日
American College of Toxicology 2026 Annual Meeting Conference American College of Toxicology 2026 Annual Meeting – – BoothCertara2023 年 5 月 24 日
ISPOR International Annual Conference 2026 Conference ISPOR International Annual Conference 2026 –Certara2023 年 2 月 15 日
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers Publication Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers Drug repurposing is promoted as a cost- and time-effective mechanism for providing new medicines. Often,…Certara2021 年 9 月 23 日
How New FDA Guidance Project Optimus May Affect Future of Oncology Clinical Trials, Drug Pipeline Press Coverage 全新 FDA 指南 Project Optimus 可能如何影响肿瘤学临床试验和药物研究计划的未来 Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the…Certara2021 年 8 月 16 日